Stock-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Stock-based Compensation Expense

Stock-based compensation expense by income statement caption and the related income tax benefit were as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In thousands)	2017		2016		2017		2016
Cost of sales	$	19	$	14	$	53	$	43
Research and development expenses	149		136		412		409
Selling, general and administrative expenses:
Employees	1,843		1,748		5,562		5,324
Outside directors	1,910		770		3,449		1,862
Total employee and director stock-based compensation expense	$	3,921	$	2,668	$	9,476	$	7,638
Income tax benefit	$	603	$	812	2,307		2,281

Schedule of Stock Option Activity

Stock option activity was as follows:

	Number of Options (in 000's)		Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in 000's)
Outstanding at December 31, 2016	652		$	39.27
Granted	92		62.70
Exercised	(45	)	24.87			$	1,893
Forfeited/canceled/expired	(168	)	46.44
Outstanding at September 30, 2017 (1)	531		$	42.26	4.49	$	11,391
Vested and expected to vest at September 30, 2017 (1)	531		$	42.26	4.49	$	11,390
Exercisable at September 30, 2017 (1)	378		$	35.35	3.94	$	10,731

⁽¹⁾  The aggregate intrinsic value represents the total pre-tax value (the difference between our closing stock price on the last trading day of the third quarter of 2017 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had they all exercised their options on September 30, 2017. This amount will change based on the fair market value of our stock.

Schedule of Black Scholes Assumptions

The assumptions we utilized in the Black-Scholes option pricing model and the resulting weighted average fair value of stock option grants were the following:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2017			2016			2017			2016
Weighted average fair value of grants	$	—		$	—		$	19.61		$	17.96
Risk-free interest rate	—		%	—		%	1.75		%	1.36		%
Expected volatility	—		%	—		%	34.25		%	41.38		%
Expected life in years	0.00			0.00			4.52			4.55

Schedule of Non-vested Restricted Stock Awards Activity

Non-vested restricted stock award activity was as follows:

	Shares (in 000's)		Weighted-Average Grant Date Fair Value
Non-vested at December 31, 2016	153		$	57.43
Granted	132		64.14
Vested	(59	)	61.28
Forfeited	(4	)	60.71
Non-vested at September 30, 2017	222		$	60.34